Last reviewed · How we verify
Ebola virus disease
Approved treatments
- Inmazeb · Regeneron
Inmazeb works by binding to the Ebola virus, preventing it from interacting with host cells and thereby reducing the severity of the disease. - Inmazeb · Regeneron
Inmazeb works by binding to the Ebola virus, preventing it from interacting with host cells. - Inmazeb · Regeneron
Inmazeb works by binding to and neutralizing the Ebola virus. - Inmazeb · ANRS, Emerging Infectious Diseases
- EBANGA · RIDGEBACK BIOTHERAPEUTICS
- Ebov Mab114 · Ridgeback Biotherapeutics
Ansuvimab works by binding to the Ebola virus glycoprotein, preventing the virus from entering host cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Ebola virus disease patent landscape — cliff calendar, originator estates, attackable patents
- Ebola virus disease treatment landscape brief
- Ebola virus disease treatment updates RSS
Frequently asked questions about Ebola virus disease
What drugs treat Ebola virus disease?
Tracked treatments include Inmazeb, EBANGA, Ebov Mab114.
What is the treatment for Ebola virus disease?
Standard treatment for Ebola virus disease includes Inmazeb, EBANGA, Ebov Mab114. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Ebola virus disease patent cliff · Ebola virus disease CI report
- Treatment: Inmazeb · Regeneron
- Treatment: Inmazeb · Regeneron
- Treatment: Inmazeb · Regeneron
- Treatment: Inmazeb · ANRS, Emerging Infectious Diseases
- Treatment: EBANGA · RIDGEBACK BIOTHERAPEUTICS
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing